Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 839720, 12 pages
http://dx.doi.org/10.1155/2011/839720
Research Article

Cognitive-Enhancing Effects of Polygalasaponin Hydrolysate in Aβ25–35-Induced Amnesic Mice

1Research Center of Pharmacology and Toxicology, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China
2Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
3Angiogenesis & Chinese Medicine Laboratory, Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK

Received 12 November 2010; Accepted 10 January 2011

Copyright © 2011 Shu ping Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Dartigues, “Alzheimer's disease: a global challenge for the 21st century,” The Lancet Neurology, vol. 8, no. 12, pp. 1082–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Blennow, M. J. de Leon, and H. Zetterberg, “Alzheimer's disease,” The Lancet, vol. 368, pp. 387–403, 2006. View at Google Scholar
  3. H. M. Chang and P. P. But, Pharmacology and Applications of Chinese Materia Medica, World Scientific, Singapore, 2001.
  4. M. Adams, F. Gmünder, and M. Hamburger, “Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature,” Journal of Ethnopharmacology, vol. 113, no. 3, pp. 363–381, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. J. Howes and P. J. Houghton, “Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function,” Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 513–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Zhang, K. Takashina, H. Saito, and N. Nishiyama, “Anti-aging effect of DX-9386 in senescence accelerated mouse,” Biological and Pharmaceutical Bulletin, vol. 17, no. 6, pp. 866–868, 1994. View at Google Scholar · View at Scopus
  7. N. Nishiyama, Y. Zhou, and H. Saito, “Beneficial effects of DX-9386, a traditional Chinese prescription, on memory disorder produced by lesioning the amygdala in mice,” Biological and Pharmaceutical Bulletin, vol. 17, no. 12, pp. 1679–1681, 1994. View at Google Scholar · View at Scopus
  8. N. Nishiyama, Y. Zhou, and H. Saito, “Ameliorative effects of chronic treatment using DX-9386, a traditional chinese prescription, on learning performance and lipid peroxide content in senescence accelerated mouse,” Biological and Pharmaceutical Bulletin, vol. 17, no. 11, pp. 1481–1484, 1994. View at Google Scholar · View at Scopus
  9. Y. S. Kwon, T. Nabeshima, E. J. Shin et al., “PAP 9704, a Korean herbal medicine attenuates methamphetamine-induced hyperlocomotion via adenosine A receptor stimulation in mice,” Biological and Pharmaceutical Bulletin, vol. 27, no. 6, pp. 906–909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Egashira, M. Yuzurihara, N. Hattori, I. Sakakibara, and A. Ishige, “Ninjin-yoei-to (Ren-Shen-Yang-Rong-Tang) and Polygalae radix improves scopolamine-induced impairment of passive avoidance response in mice,” Phytomedicine, vol. 10, no. 6-7, pp. 467–473, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Y. Lee, K. Y. Kim, K. Y. Shin, B. Y. Won, H. Y. Jung, and Y. H. Suh, “Effects of BT-11 on memory in healthy humans,” Neuroscience Letters, vol. 454, no. 2, pp. 111–114, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. Y. Shin, J. Y. Lee, B. Y. Won et al., “BT-11 is effective for enhancing cognitive functions in the elderly humans,” Neuroscience Letters, vol. 465, no. 2, pp. 157–159, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. Y. Ikeya, S. Takeda, M. Tunakawa et al., “Cognitive improving and cerebral protective effects of acylated oligosaccharides in Polygala tenuifolia,” Biological and Pharmaceutical Bulletin, vol. 27, no. 7, pp. 1081–1085, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhang, T. Han, L. Zhang et al., “Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice,” Phytomedicine, vol. 15, no. 8, pp. 587–594, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. X. L. Sun, H. Ito, T. Masuoka, C. Kamei, and T. Hatano, “Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task,” Biological and Pharmaceutical Bulletin, vol. 30, no. 9, pp. 1727–1731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Y. Shin, B. Y. Won, C. Heo et al., “BT-11 improves stress-induced memory impairments through increment of glucose utilization and total neural cell adhesion molecule levels in rat brains,” Journal of Neuroscience Research, vol. 87, no. 1, pp. 260–268, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. F. Karakida, Y. Ikeya, M. Tsunakawa et al., “Cerebral protective and cognition-improving effects of sinapic acid in rodents,” Biological and Pharmaceutical Bulletin, vol. 30, no. 3, pp. 514–519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. C. Zhang and L. W. Wang, “Effect of extracts from Polygala tenuifolia on learning and memory abilities of mice,” Chinese Journal of New Drugs, vol. 15, pp. 1254–1257, 2006 (Chinese). View at Google Scholar
  19. F. Tian, Y. Jiang, K. Zhang, X. W. Liu, and Z. Y. Zhang, “The effect and mechanism of polygala tenuifolia glycoside on SAM-P/8,” Geriatr Health Care, vol. 10, pp. 137–139, 2004 (Chinese). View at Google Scholar
  20. X. M. Chen, X. Xie, J. J. Sun et al., “Study on acute toxicity and learning-memory improvement of schisandra chinensis and polygala tenuifolia extracts,” Practical Preventive Medicine, vol. 13, pp. 807–809, 2006 (Chinese). View at Google Scholar
  21. H. H. Wu, J. Wang, X. W. Liu, H. Z. Bao, and H. P. Zhao, “Effects on acute toxicity and gastrointestinal motility between various Honey-stir-baked and Crude Radix Polygalae,” Journal of Sichuan of Traditional Chinese Medicine, vol. 24, pp. 16–18, 2006 (Chinese). View at Google Scholar
  22. H. J. Park, K. Lee, H. Heo et al., “Effects of Polygala tenuifolia root extract on proliferation of neural stem cells in the hippocampal CA1 region,” Phytotherapy Research, vol. 22, no. 10, pp. 1324–1329, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. A. Lacaille-Dubois and A. C. Mitaine-Offer, “Triterpene saponins from Polygalaceae,” Phytochemistry Reviews, vol. 4, no. 2-3, pp. 139–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Giovannelli, F. Casamenti, C. Scali, L. Bartolini, and G. Pepeu, “Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis,” Neuroscience, vol. 66, no. 4, pp. 781–792, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Paxinos and K. Franklin, The Mouse Brain in Stereotaxic Coordinates, Academic Press, A Harcourt Science and Technology Company, New York, NY, USA, 2001.
  26. Q. Wang, L. H. Sun, W. Jia et al., “Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine-induced learning and memory impairment in mice,” Phytotherapy Research, vol. 24, no. 12, pp. 1748–1754, 2010. View at Publisher · View at Google Scholar · View at PubMed
  27. W. L. Mai, Q. Wang, X. M. Liu et al., “Significant parameters in evaluation of spontaneous activity in mice,” Acta Laboratorium Animalis Scientia Sinica, pp. 172–176, 2008 (Chinese). View at Google Scholar
  28. H. Dang, Y. Chen, X. Liu et al., “Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 8, pp. 1417–1424, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. R. Morris, “Developments of a water-maze procedure for studying spatial learning in the rat,” Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47–60, 1984. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Xue, S. G. Chen, S. P. Xu et al., “Establishment of a highly automated and intelligent experimental system of passive avoidance for mice,” Journal of Clinical Rehabilitative Tissue Engineering Research, vol. 14, no. 15, pp. 2778–2782, 2010 (Chinese). View at Publisher · View at Google Scholar
  31. R. Medeiros, R. D. S. Prediger, G. F. Passos et al., “Connecting TNF-α signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid β protein,” Journal of Neuroscience, vol. 27, no. 20, pp. 5394–5404, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  33. J. F. Flood, J. E. Morley, and E. Roberts, “Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 8, pp. 3363–3366, 1991. View at Google Scholar · View at Scopus
  34. A. Nitta, A. Itoh, T. Hasegawa, and T. Nabeshima, “β-amyloid protein-induced Alzheimer's disease animal model,” Neuroscience Letters, vol. 170, no. 1, pp. 63–66, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. R. D. S. Prediger, R. Medeiros, P. Pandolfo et al., “Genetic deletion or antagonism of kinin B1 and B2 receptors improves cognitive deficits in a mouse model of Alzheimer's disease,” Neuroscience, vol. 151, no. 3, pp. 631–643, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. R. Christensen, A. B. Marcussen, G. Wörtwein, G. M. Knudsen, and S. Aznar, “Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels,” Experimental Neurology, vol. 210, no. 1, pp. 164–171, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. T. Maurice, B. P. Lockhart, and A. Privat, “Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction,” Brain Research, vol. 706, no. 2, pp. 181–193, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Maurice, T.-P. Su, and A. Privat, “Sigma1 (q) receptor agonists and neurosteroids attenuate b25-35-amyloid peptide-induced amnesia in mice through a common mechanism,” Neuroscience, vol. 83, no. 2, pp. 413–428, 1998. View at Google Scholar
  39. C. Behl, J. B. Davis, R. Lesley, and D. Schubert, “Hydrogen peroxide mediates amyloid β protein toxicity,” Cell, vol. 77, no. 6, pp. 817–827, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Behl, “Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease,” Cell and Tissue Research, vol. 290, no. 3, pp. 471–480, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Steele, G. Stuchbury, and G. Münch, “The molecular basis of the prevention of Alzheimer's disease through healthy nutrition,” Experimental Gerontology, vol. 42, no. 1-2, pp. 28–36, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. M. M. Boccia, M. G. Blake, M. C. Krawczyk, and C. M. Baratti, “Hippocampal alpha7 nicotinic receptors modulate memory reconsolidation of an inhibitory avoidance task in mice,” Neuroscience, vol. 171, no. 2, pp. 531–543, 2010. View at Publisher · View at Google Scholar · View at PubMed
  43. D. Jerusalinsky, J. A. Quillfeldt, R. Walz, R. C. Da Silva, J. H. Medina, and I. Izquierdo, “Post-training intrahippocampal infusion of protein kinase C inhibitors causes amnesia in rats,” Behavioral and Neural Biology, vol. 61, no. 2, pp. 107–109, 1994. View at Google Scholar · View at Scopus
  44. M. R. Tinsley, J. J. Quinn, and M. S. Fanselow, “The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: comparing pavlovian fear conditioning and inhibitory avoidance,” Learning and Memory, vol. 11, no. 1, pp. 35–42, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. M. E. Bach, M. Barad, H. Son et al., “Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 9, pp. 5280–5285, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. R. D'Hooge and P. P. De Deyn, “Applications of the Morris water maze in the study of learning and memory,” Brain Research Reviews, vol. 36, no. 1, pp. 60–90, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. G. D. Gale, S. G. Anagnostaras, B. P. Godsil et al., “Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats,” Journal of Neuroscience, vol. 24, no. 15, pp. 3810–3815, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. D. Van Dam, D. Abramowski, M. Staufenbiel, and P. P. De Deyn, “Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model,” Psychopharmacology, vol. 180, no. 1, pp. 177–190, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. R. J. Fishkin, E. S. Ince, W. A. Carlezon, and R. W. Dunn, “D-cycloserine attenuates scopolamine-induced learning and memory,” Behavioral and Neural Biology, vol. 59, no. 2, pp. 150–157, 1993. View at Google Scholar · View at Scopus
  50. P. Chopin and M. Briley, “Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats,” Psychopharmacology, vol. 106, no. 1, pp. 26–30, 1992. View at Google Scholar · View at Scopus
  51. G. M. Bores, F. P. Huger, W. Petko et al., “Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine,” Journal of Pharmacology and Experimental Therapeutics, vol. 277, no. 2, pp. 728–738, 1996. View at Google Scholar · View at Scopus
  52. J. E. Sweeney, P. A. Puttfarcken, and J. T. Coyle, “Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice,” Pharmacology Biochemistry and Behavior, vol. 34, no. 1, pp. 129–137, 1989. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Burns, R. Bernabei, R. Bullock et al., “Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial,” The Lancet Neurology, vol. 8, no. 1, pp. 39–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Varadarajan, J. Kanski, M. Aksenova, C. Lauderback, and D. A. Butterfield, “Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1–42) and Aβ(25–35),” Journal of the American Chemical Society, vol. 123, no. 24, pp. 5625–5631, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. D. A. Butterfield, J. Drake, C. Pocernich, and A. Castegna, “Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide,” Trends in Molecular Medicine, vol. 7, no. 12, pp. 548–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. J. T. Coyle and P. Puttfarcken, “Oxidative stress, glutamate, and neurodegenerative disorders,” Science, vol. 262, no. 5134, pp. 689–695, 1993. View at Google Scholar · View at Scopus
  57. B. N. Ames, M. K. Shigenaga, and T. M. Hagen, “Oxidants, antioxidants, and the degenerative diseases of aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915–7922, 1993. View at Google Scholar · View at Scopus
  58. M. Y. Um, W. H. Choi, J. Y. Aan, S. R. Kim, and T. Y. Ha, “Protective effect of Polygonum multiflorum Thunb on amyloid β-peptide 25-35 induced cognitive deficits in mice,” Journal of Ethnopharmacology, vol. 104, no. 1-2, pp. 144–148, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus